| Field | Specification |
|---|---|
| Mfr No | |
| Alternative Names | Alpl ELISA Kit; Akp-2 ELISA Kit; Akp2 ELISA Kit; Alkaline phosphatase ELISA Kit; tissue-nonspecific isozyme ELISA Kit; AP-TNAP ELISA Kit; TNSALP ELISA Kit; EC 3.1.3.1 ELISA Kit; Alkaline phosphatase 2 ELISA Kit; Alkaline phosphatase liver/bone/kidney isozyme ELISA Kit |
| Assay Time | |
| Assay Type | |
| Detection Range | |
| Detection Wavelength | |
| Product Type | |
| Reactivity | |
| Sample Type(s) | serum, plasma, tissue homogenates |
| Sensitivity | |
| Species | |
| Target | |
| UniProt # |
Background
Bone-specific alkaline phosphatase (BALP) is a biological molecule commonly studied in others research. It is commonly used as a molecular readout in mechanistic and biomarker-focused studies.
UniProt: P09242
Biological context
Researchers often monitor Bone-specific alkaline phosphatase (BALP) in serum, plasma, and tissue homogenates to better understand themes such as mechanistic biology studies, biomarker-focused profiling, and disease-model research. In many model systems, measured levels can shift with physiology, experimental perturbation, or disease-associated changes, making careful biological interpretation important.
Interpreting changes in measured levels
Depending on sample matrix and study design, increases or decreases in Bone-specific alkaline phosphatase (BALP) may reflect differences in expression, secretion, turnover, or compartmentalization rather than a single mechanism. Interpretation is typically strengthened by evaluating related molecules (for example, complementary pathway markers and controls appropriate to the biological model) and by keeping pre-analytical variables consistent across groups.
Nomenclature
In publications and databases, Bone-specific alkaline phosphatase (BALP) may also appear under names such as Alpl and Akp-2. When comparing studies, confirm that the reported analyte refers to the same molecule and species context.
Why ELISA data are widely used
ELISA is a common approach for quantitative measurement of proteins and biomarkers in complex samples, enabling comparisons across experimental groups and time points. When integrating results with other readouts, consider species biology, sample type, and the broader pathway context that Bone-specific alkaline phosphatase (BALP) participates in.
Can’t Find What You’re Looking For? We can help you source the best match or customize an ELISA solution for your study. Options may include alternative target synonyms, different species reactivity, sample type/matrix compatibility (serum/plasma/lysate/supernatant), assay format (sandwich/competitive), sensitivity/range, detection chemistry (colorimetric/fluorescent/chemiluminescent), plate format (pre-coated/uncoated, strips vs full plate), and bulk or custom packaging. Click Talk to a Scientist to submit a request form, email us at support@biohippo.com, or explore our Research Services for additional support. Our team will be in contact with you shortly.
Accumulation of advanced oxidation protein products aggravates bone-fat imbalance during skeletal aging
YS Huang, JW Gao, RF Ao, XY Liu, DZ Wu,Journal of Orthopaedic Translation,2025
The crucial role of beta-catenin in the osteoprotective effect of semaglutide in an ovariectomized rat model of osteoporosis
MHH Abo-Elenin, R Kamel, S Nofal,Naunyn-Schmiedeberg's Archives of Pharmacology,2024
Ulmus macrocarpa Hance trunk bark extracts inhibit RANKL-induced osteoclast differentiation and prevent ovariectomy-induced osteoporosis in mice
C Jeong,Journal of ethnopharmacology,2024
Icariin promotes bone marrow mesenchymal stem cells osteogenic differentiation via the mTOR/autophagy pathway to improve ketogenic diet-associated osteoporosis
HY Yu,Journal of orthopaedic surgery and research,2024
Bone-targeting engineered small extracellular vesicles carrying anti-miR-6359-CGGGAGC prevent valproic acid-induced bone loss
M Ghoneum,Signal transduction and targeted therapy,2024
Malt1 deficient mice develop osteoporosis independent of osteoclast-intrinsic effects of Malt1 deficiency
Monajemi M, et al,Journal of Leukocyte Biology,2019
Renal involvement in the pathogenesis of mineral and bone disorder in dystrophin-deficient mdx mouse
Wada E,The Journal of Physiological Sciences,2019
Significance of the Tks4 scaffold protein in bone tissue homeostasis
Vas V, et al,Scientific Reports,2019
Rapamycin improves bone mass in high-turnover osteoporosis with iron accumulation through positive effects on osteogenesis and angiogenesis
Wu J, et al,Bone,2019
Apoptosis‐associated speck‐like protein containing a caspase‐1 recruitment domain (ASC) contributes to osteoblast differentiation and osteogenesis
Suelen Sartoretto.et al,journal of cellular physiology,2018
Metformin Alleviates the Bone Loss Induced by Ketogenic Diet: An In Vivo Study in Mice
Qi Liu.et al,Calcified Tissue International,2018
Germinated soy germ with increased soyasaponin Ab improves BMP-2-induced bone formation and protects against in vivo bone loss in osteoporosis
Chan-Woong Choi.et al,Scientific Reports,2018
FGF23 is synthesised locally by renal tubules and activates injury-primed fibroblasts
Smith ER.et al,Sci Rep,2017
Milk Basic Protein Facilitates Increased Bone Mass in Growing Mice
Ono-Ohmachi A.et al,J Nutr Sci Vitaminol (Tokyo),2017
AGENT FOR PREVENTING OR IMPROVING SYMPTOMS CAUSED BY IMBALANCE OF SEX HORMONES
Ghizzani A.et al,J Endocrinol Invest,2017
Low neural exosomal levels of cellular survival factors in Alzheimer's disease
Edward J. Goetzl. et al,Annals of Clinical and Translational Neurology,2015
HYPOXIA-REPERFUSION AFFECTS OSTEOGENIC LINEAGE AND PROMOTES SICKLE CELL BONE DISEASE
Dalle Carbonare L. et al,Blood,2015
Deficiency of chemokine receptor CCR1 causes osteopenia due to impaired functions of osteoclasts and osteoblasts
/,Journal of Biological Chemistry,2010